Distinct fecal metabolites identified for non-invasive diagnosis of endometriosis

Researchers identify distinct gut microbiome metabolites in women with endometriosis, offering potential for non-invasive diagnosis and new therapies.

PlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery disease

PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), and RxCelerate, a leading international out-sourced drug discovery and development service provider, today

September 18, 2024

Bristol Myers Squibb’s Abecma recommended for EU approval

Share this article EMA CHMP endorses Bristol Myers Squibb’s Abecma for the treatment of adult multiple myeloma patients in the EU. Credit: Amy Lutz /

January 29, 2024

Blind employee takes VA to court saying new EHR from Oracle is inaccessible

A blind employee of the Department of Veterans Affairs is suing the federal agency on grounds that their new electronic health records system makes it

June 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.